Anaheim, California
Alzheimer's disease clinical trials in Anaheim, CA
8 Alzheimer's disease studies are recruiting participants at sites in Anaheim as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Anaheim at a glance
- 8 studies are recruiting at a site in Anaheim.
- By phase: Phase 1 (2), Phase 2 (3), Phase 3 (3).
- By sponsor: industry (8).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Anaheim
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Advanced Research Center, Inc.
- Registry record
- NCT05980949 · updated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Advanced Research Center (ARC) - Anaheim
- Registry record
- NCT07011732 · updated
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
- Phase 1
- Ages 18 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- CenExel ACT
- Registry record
- NCT07787169 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Advanced Research Center, Inc
- Registry record
- NCT06540833 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Advanced Research Center, Inc
- Registry record
- NCT06651567 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Advanced Research Center, Inc.
- Registry record
- NCT06585787 · updated
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Phase 1
- Ages 18 to 80
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- CenExel ACT (Formerly Anaheim Clinical Trials; LLC)
- Registry record
- NCT07780383 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Anaheim, CA on ClinicalTrials.gov.
Ask about studies near Anaheim
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
62 studies recruiting across 36 cities.
Los Angeles
16 studies recruiting.
San Francisco
11 studies recruiting.
Irvine
10 studies recruiting.
Long Beach
9 studies recruiting.
Orange
7 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections